JPMorgan analyst Jeffrey Zekaukas downgraded Eastman Chemical (NYSE: EMN) from Overweight to Neutral with a price target of $66.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades